Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03777059
Brief Title: To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine

First Submitted : December 13, 2018
First Submitted that Met QC Criteria : December 13, 2018
First Posted : December 17, 2018

Last Update Submitted that Met QC Criteria : April 9, 2019
Last Update Posted : April 10, 2019